Charlotte's Web Holdings (CWBHF) Consolidated Net Income (2021 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Consolidated Net Income of -$13.1 million for Q1 2026, down 111.08% year-over-year from $118.4 million in Q1 2025, and down 14.79% quarter-over-quarter from -$11.4 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Consolidated Net Income (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Consolidated Net Income for 6 consecutive years, with -$13.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Consolidated Net Income fell 111.08% year-over-year to -$13.1 million; the TTM figure through Mar 2026 stood at -$36.6 million (down 38.67% YoY), while the FY2025 annual figure was -$29.7 million, changed 0.35% from the prior year.
- Consolidated Net Income eased to -$13.1 million in Q1 2026 per CWBHF's latest filing, from -$11.4 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $2.8 million in Q2 2023 and bottomed at -$35.2 million in Q4 2022.
- Historically, Consolidated Net Income has averaged -$9.2 million across 5 years, with a median of -$7.9 million in 2022.
- Annual changes were most pronounced in 2022 — Consolidated Net Income sank 876.58% — and 2023, when it surged 136.14%.
- Charlotte's Web Holdings' Consolidated Net Income stood at -$35.2 million in 2022, then surged by 75.63% to -$8.6 million in 2023, then jumped by 60.77% to -$3.4 million in 2024, then plunged by 239.16% to -$11.4 million in 2025, then decreased by 14.79% to -$13.1 million in 2026.
- Business Quant data shows CWBHF's Consolidated Net Income at -$13.1 million in Q1 2026, -$11.4 million in Q4 2025, and -$5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Charlotte's Web Holdings | 58.27 Mn | 44.28 Mn | 5.16 Mn | -4.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.13 Mn |
| Mar 31, 2026 | -13.11 Mn |
| Dec 31, 2025 | -11.42 Mn |
| Sep 30, 2025 | -5.82 Mn |
| Jun 30, 2025 | -6.29 Mn |
| Mar 31, 2025 | -6.21 Mn |
| Dec 31, 2024 | -3.37 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Jun 30, 2024 | -11.06 Mn |
| Mar 31, 2024 | -9.63 Mn |
| Dec 31, 2023 | -8.59 Mn |
| Sep 30, 2023 | -15.14 Mn |
| Jun 30, 2023 | 2.84 Mn |
| Mar 31, 2023 | -2.91 Mn |
| Dec 31, 2022 | -35.23 Mn |
| Sep 30, 2022 | -7.59 Mn |
| Jun 30, 2022 | -7.87 Mn |
| Mar 31, 2022 | -8.63 Mn |
| Dec 31, 2021 | -118.25 Mn |
| Sep 30, 2021 | -777,000.00 |